Tapewire

Nasdaq · USD

PMCB

PharmaCyte Biotech, Inc.

Export transactions ↓
Tapewire entity
8256
SEC CIK
0001157075
Parsed reports
42

Last 12 months

Inside the activity.

6 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202660
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 31, 2026 Filed Apr 2, 2026 22:17 UTC GrantStock Option (Right to Buy) · Derivative 119,170 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0001683168-26-002633 · ownership.xml · derivative · entry 1

WEINSTEIN ROBERT · CIK 0001213709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,170

Underlying: Common Stock · 119,170 shares

Expires 2036-03-30

F1 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 22:17 UTC GrantStock Option (Right to Buy) · Derivative 119,170 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0001683168-26-002632 · ownership.xml · derivative · entry 1

WALKER WAYNE REMELL · CIK 0001428761 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,170

Underlying: Common Stock · 119,170 shares

Expires 2036-03-30

F1 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 22:17 UTC GrantStock Option (Right to Buy) · Derivative 119,170 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0001683168-26-002631 · ownership.xml · derivative · entry 1

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,170

Underlying: Common Stock · 119,170 shares

Expires 2036-03-30

F1 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 22:16 UTC GrantStock Option (Right to Buy) · Derivative 119,170 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0001683168-26-002630 · ownership.xml · derivative · entry 1

Abecassis Michael M · CIK 0001879281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,170

Underlying: Common Stock · 119,170 shares

Expires 2036-03-30

F1 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis.

Read SEC document
March 31, 2026 Filed Jul 17, 2026 21:00 UTC Amendment OtherStock Option (Right to Buy) · Derivative 0 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-26-005622 · ownership.xml · derivative · entry 1

WALKER WAYNE REMELL · CIK 0001428761 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

F1 · security: The reported grant was made in error and has been cancelled.

F1 · derivative.exercise_price: The reported grant was made in error and has been cancelled.

F1 · date: The reported grant was made in error and has been cancelled.

F1 · kind: The reported grant was made in error and has been cancelled.

F1 · shares: The reported grant was made in error and has been cancelled.

F1 · price: The reported grant was made in error and has been cancelled.

F1 · derivative.exercise_date: The reported grant was made in error and has been cancelled.

F1 · derivative.expiration_date: The reported grant was made in error and has been cancelled.

F1 · derivative.underlying: The reported grant was made in error and has been cancelled.

F1 · derivative.underlying_shares: The reported grant was made in error and has been cancelled.

F1 · balance_after: The reported grant was made in error and has been cancelled.

Read SEC document
March 31, 2026 Filed Jul 17, 2026 21:00 UTC Amendment OtherStock Option (Right to Buy) · Derivative 0 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-26-005621 · ownership.xml · derivative · entry 1

Abecassis Michael M · CIK 0001879281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

F1 · security: The reported grant was made in error and has been cancelled.

F1 · derivative.exercise_price: The reported grant was made in error and has been cancelled.

F1 · date: The reported grant was made in error and has been cancelled.

F1 · kind: The reported grant was made in error and has been cancelled.

F1 · shares: The reported grant was made in error and has been cancelled.

F1 · price: The reported grant was made in error and has been cancelled.

F1 · derivative.exercise_date: The reported grant was made in error and has been cancelled.

F1 · derivative.expiration_date: The reported grant was made in error and has been cancelled.

F1 · derivative.underlying: The reported grant was made in error and has been cancelled.

F1 · derivative.underlying_shares: The reported grant was made in error and has been cancelled.

F1 · balance_after: The reported grant was made in error and has been cancelled.

Read SEC document
March 31, 2026 Filed Jul 17, 2026 21:00 UTC Amendment OtherStock Option (Right to Buy) · Derivative 0 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-26-005620 · ownership.xml · derivative · entry 1

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

F1 · security: The reported grant was made in error and has been cancelled.

F1 · derivative.exercise_price: The reported grant was made in error and has been cancelled.

F1 · date: The reported grant was made in error and has been cancelled.

F1 · kind: The reported grant was made in error and has been cancelled.

F1 · shares: The reported grant was made in error and has been cancelled.

F1 · price: The reported grant was made in error and has been cancelled.

F1 · derivative.exercise_date: The reported grant was made in error and has been cancelled.

F1 · derivative.expiration_date: The reported grant was made in error and has been cancelled.

F1 · derivative.underlying: The reported grant was made in error and has been cancelled.

F1 · derivative.underlying_shares: The reported grant was made in error and has been cancelled.

F1 · balance_after: The reported grant was made in error and has been cancelled.

Read SEC document
March 31, 2026 Filed Jul 17, 2026 21:00 UTC Amendment OtherStock Option (Right to Buy) · Derivative 0 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-26-005619 · ownership.xml · derivative · entry 1

WEINSTEIN ROBERT · CIK 0001213709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

F1 · security: The reported grant was made in error and has been cancelled.

F1 · derivative.exercise_price: The reported grant was made in error and has been cancelled.

F1 · date: The reported grant was made in error and has been cancelled.

F1 · kind: The reported grant was made in error and has been cancelled.

F1 · shares: The reported grant was made in error and has been cancelled.

F1 · price: The reported grant was made in error and has been cancelled.

F1 · derivative.exercise_date: The reported grant was made in error and has been cancelled.

F1 · derivative.expiration_date: The reported grant was made in error and has been cancelled.

F1 · derivative.underlying: The reported grant was made in error and has been cancelled.

F1 · derivative.underlying_shares: The reported grant was made in error and has been cancelled.

F1 · balance_after: The reported grant was made in error and has been cancelled.

Read SEC document
January 07, 2026 Filed Jan 7, 2026 22:43 UTC
Silverman JoshuaDirector · CEO and President
PurchaseCommon Stock 40,000 $0.83 $33,316.00
Disclosure

SEC source: 0001683168-26-000148 · ownership.xml · nonDerivative · entry 3

Silverman Joshua · CIK 0001524858 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 416,250

Read SEC document
January 07, 2026 Filed Jan 7, 2026 22:43 UTC PurchaseCommon Stock 20,000 $0.84 $16,872.00
Disclosure

SEC source: 0001683168-26-000147 · ownership.xml · nonDerivative · entry 3

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,500

Read SEC document
January 06, 2026 Filed Jan 7, 2026 22:43 UTC
Silverman JoshuaDirector · CEO and President
PurchaseCommon Stock 30,000 $0.79 $23,667.00
Disclosure

SEC source: 0001683168-26-000148 · ownership.xml · nonDerivative · entry 2

Silverman Joshua · CIK 0001524858 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,250

Read SEC document
January 06, 2026 Filed Jan 7, 2026 22:43 UTC PurchaseCommon Stock 20,000 $0.79 $15,808.00
Disclosure

SEC source: 0001683168-26-000147 · ownership.xml · nonDerivative · entry 2

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,500

Read SEC document
January 05, 2026 Filed Jan 7, 2026 22:43 UTC
Silverman JoshuaDirector · CEO and President
PurchaseCommon Stock 30,000 $0.78 $23,493.00
Disclosure

SEC source: 0001683168-26-000148 · ownership.xml · nonDerivative · entry 1

Silverman Joshua · CIK 0001524858 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,250

Read SEC document
January 05, 2026 Filed Jan 7, 2026 22:43 UTC PurchaseCommon Stock 20,000 $0.78 $15,552.00
Disclosure

SEC source: 0001683168-26-000147 · ownership.xml · nonDerivative · entry 1

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,500

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:08 UTC Tax withholdingCommon Stock 33,750 $1.02 $34,425.00
Disclosure

SEC source: 0001683168-25-009116 · ownership.xml · nonDerivative · entry 2

WEINSTEIN ROBERT · CIK 0001213709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,250

F1 · shares: Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:08 UTC GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001683168-25-009116 · ownership.xml · nonDerivative · entry 1

WEINSTEIN ROBERT · CIK 0001213709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:07 UTC Tax withholdingCommon Stock 16,875 $1.02 $17,212.50
Disclosure

SEC source: 0001683168-25-009115 · ownership.xml · nonDerivative · entry 2

WALKER WAYNE REMELL · CIK 0001428761 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,625

F1 · shares: Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:07 UTC GrantCommon Stock 37,500 $0.00 $0.00
Disclosure

SEC source: 0001683168-25-009115 · ownership.xml · nonDerivative · entry 1

WALKER WAYNE REMELL · CIK 0001428761 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:07 UTC Tax withholdingCommon Stock 67,500 $1.02 $68,850.00
Disclosure

SEC source: 0001683168-25-009113 · ownership.xml · nonDerivative · entry 2

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,500

F1 · shares: Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:07 UTC GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001683168-25-009113 · ownership.xml · nonDerivative · entry 1

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:07 UTC
Silverman JoshuaDirector · CEO and President
Tax withholdingCommon Stock 258,750 $1.02 $263,925.00
Disclosure

SEC source: 0001683168-25-009114 · ownership.xml · nonDerivative · entry 2

Silverman Joshua · CIK 0001524858 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,250

F1 · shares: Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:07 UTC
Silverman JoshuaDirector · CEO and President
GrantCommon Stock 575,000 $0.00 $0.00
Disclosure

SEC source: 0001683168-25-009114 · ownership.xml · nonDerivative · entry 1

Silverman Joshua · CIK 0001524858 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 575,000

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:06 UTC Tax withholdingCommon Stock 16,875 $1.02 $17,212.50
Disclosure

SEC source: 0001683168-25-009112 · ownership.xml · nonDerivative · entry 2

Abecassis Michael M · CIK 0001879281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,292

F1 · shares: Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.

Read SEC document
December 12, 2025 Filed Dec 12, 2025 22:06 UTC GrantCommon Stock 37,500 $0.00 $0.00
Disclosure

SEC source: 0001683168-25-009112 · ownership.xml · nonDerivative · entry 1

Abecassis Michael M · CIK 0001879281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,167

Read SEC document
April 25, 2025 Filed Dec 12, 2025 22:08 UTC GrantStock Option (Right to Buy) · Derivative 63,233 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001683168-25-009116 · ownership.xml · derivative · entry 3

WEINSTEIN ROBERT · CIK 0001213709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,233

Underlying: Common Stock · 63,233 shares

Expires 2035-04-24

F2 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein. This transaction is late due to an inadvertent administrative error and not any error of Mr. Weinstein.

Read SEC document
April 25, 2025 Filed Dec 12, 2025 22:07 UTC GrantStock Option (Right to Buy) · Derivative 63,233 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001683168-25-009115 · ownership.xml · derivative · entry 3

WALKER WAYNE REMELL · CIK 0001428761 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,233

Underlying: Common Stock · 63,233 shares

Expires 2035-04-24

F2 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker. This transaction is late due to an inadvertent administrative error and not any error of Mr. Walker.

Read SEC document
April 25, 2025 Filed Dec 12, 2025 22:07 UTC GrantStock Option (Right to Buy) · Derivative 63,233 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001683168-25-009113 · ownership.xml · derivative · entry 3

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,233

Underlying: Common Stock · 63,233 shares

Expires 2035-04-24

F2 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter.

Read SEC document
April 25, 2025 Filed Dec 12, 2025 22:06 UTC GrantStock Option (Right to Buy) · Derivative 63,233 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001683168-25-009112 · ownership.xml · derivative · entry 4

Abecassis Michael M · CIK 0001879281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,233

Underlying: Common Stock · 63,233 shares

Expires 2035-04-24

F2 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis.

Read SEC document
April 30, 2024 Filed Jul 17, 2024 20:58 UTC GrantStock Option (Right to Buy) · Derivative 38,009 $0.00 Strike: $2.12 $0.00
Disclosure

SEC source: 0001683168-24-004917 · ownership.xml · derivative · entry 1

WALKER WAYNE REMELL · CIK 0001428761 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,009

Underlying: Common Stock · 38,009 shares

Expires 2034-04-30

F1 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker. This transaction is late due to an inadvertent administrative error and not any error of Mr. Walker.

Read SEC document
April 30, 2024 Filed Jul 17, 2024 20:59 UTC GrantStock Option (Right to Buy) · Derivative 38,009 $0.00 Strike: $2.12 $0.00
Disclosure

SEC source: 0001683168-24-004918 · ownership.xml · derivative · entry 1

WEINSTEIN ROBERT · CIK 0001213709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,009

Underlying: Common Stock · 38,009 shares

Expires 2034-04-30

F1 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein. This transaction is late due to an inadvertent administrative error and not any error of Mr. Weinstein.

Read SEC document
April 30, 2024 Filed Jul 17, 2024 20:58 UTC GrantStock Option (Right to Buy) · Derivative 38,009 $0.00 Strike: $2.12 $0.00
Disclosure

SEC source: 0001683168-24-004916 · ownership.xml · derivative · entry 1

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,009

Underlying: Common Stock · 38,009 shares

Expires 2034-04-30

F1 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter.

Read SEC document
April 30, 2024 Filed Jul 17, 2024 20:58 UTC GrantStock Option (Right to Buy) · Derivative 38,009 $0.00 Strike: $2.12 $0.00
Disclosure

SEC source: 0001683168-24-004915 · ownership.xml · derivative · entry 1

Abecassis Michael M · CIK 0001879281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,009

Underlying: Common Stock · 38,009 shares

Expires 2034-04-30

F1 · derivative.exercise_date: The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 22:02 UTC GrantStock Option (Right to Buy) · Derivative 61,248 $0.00 Strike: $2.18 $0.00
Disclosure

SEC source: 0001683168-23-008434 · ownership.xml · derivative · entry 1

WEINSTEIN ROBERT · CIK 0001213709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,248

Underlying: Common Stock · 61,248 shares

Expires 2033-11-20

Read SEC document
November 20, 2023 Filed Nov 22, 2023 22:02 UTC GrantStock Option (Right to Buy) · Derivative 61,248 $0.00 Strike: $2.18 $0.00
Disclosure

SEC source: 0001683168-23-008433 · ownership.xml · derivative · entry 1

WALKER WAYNE REMELL · CIK 0001428761 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,248

Underlying: Common Stock · 61,248 shares

Expires 2033-11-20

Read SEC document
November 20, 2023 Filed Nov 22, 2023 22:01 UTC
Silverman JoshuaDirector · Interim CEO, Interim President
GrantStock Option (Right to Buy) · Derivative 170,000 $0.00 Strike: $2.18 $0.00
Disclosure

SEC source: 0001683168-23-008431 · ownership.xml · derivative · entry 1

Silverman Joshua · CIK 0001524858 · Director · Interim CEO, Interim President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires 2033-11-20

F1 · derivative.exercise_date: The options vest 50% on November 20, 2023 and 50% on November 20, 2024.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 22:01 UTC
Trujillo CarlosDirector · Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 85,000 $0.00 Strike: $2.18 $0.00
Disclosure

SEC source: 0001683168-23-008432 · ownership.xml · derivative · entry 1

Trujillo Carlos · CIK 0001464520 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2033-11-20

F1 · derivative.exercise_date: The options vest 50% on November 20, 2023 and 50% on November 20, 2024.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 22:01 UTC GrantStock Option (Right to Buy) · Derivative 61,248 $0.00 Strike: $2.18 $0.00
Disclosure

SEC source: 0001683168-23-008430 · ownership.xml · derivative · entry 1

SCHECHTER JONATHAN · CIK 0001619259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,248

Underlying: Common Stock · 61,248 shares

Expires 2033-11-20

Read SEC document
November 20, 2023 Filed Nov 22, 2023 22:00 UTC GrantStock Option (Right to Buy) · Derivative 61,248 $0.00 Strike: $2.18 $0.00
Disclosure

SEC source: 0001683168-23-008429 · ownership.xml · derivative · entry 1

Abecassis Michael M · CIK 0001879281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,248

Underlying: Common Stock · 61,248 shares

Expires 2033-11-20

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:05 UTC GrantStock Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $2.97 $0.00
Disclosure

SEC source: 0001683168-22-008707 · ownership.xml · derivative · entry 1

Farb Daniel Stuart · CIK 0001776353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2032-11-14

F1 · date: The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the "2022 Plan"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022.

F1 · derivative.exercise_date: The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the "2022 Plan"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:05 UTC
Allen DanielDirector
GrantStock Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $2.97 $0.00
Disclosure

SEC source: 0001683168-22-008706 · ownership.xml · derivative · entry 1

Allen Daniel · CIK 0001736605 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2032-11-14

F1 · date: The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the "2022 Plan"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022.

F1 · derivative.exercise_date: The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the "2022 Plan"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.